Thus, SUMOylation of METTL3 decreases the global cellular abundance of the m6A mark and subsequently alters the transcriptome of m6A-modified RNAs in cells, facilitating the development of NSCLC. The gene discussed is METTL3; the disease is non-small cell lung carcinoma.